Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ryzodeg vs Insulin Detemir in Type 1 Diabetes (BOOST T1)
NCT00978627Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Aug 2009
- Primary completion
- May 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 10
01
Overview
A Phase 3 trial of insulin degludec + insulin aspart in type 1 diabetes mellitus (T1D), sponsored by Novo Nordisk. Started Aug 2009; status: completed.
02
Drugs
insulin degludec + insulin aspart
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00978627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00978627.